Prenatal exposure to maternal depression alters characteristics of EEG bursting activity during infancy. Exposure to serotonin selective reuptake inhibitors (SSRIs) during pregnancy also alters characteristics of EEG bursting activity during infancy, but differently than maternal depression. Assessment of infant EEG bursting activity affords a new early life marker for changes in brain development caused by maternal depression and/or SSRI use.
Introduction
The use of SSRI medications during pregnancy has increased many-fold over the last 30 years in response to the concerns about the effects of untreated psychiatric symptoms on both the mother and the gestating fetus. SSRIs administered during pregnancy ini-tially enters the maternal bloodstream and then pass through the placenta into the fetal blood stream. At birth the infant serum levels are approximately one third of the maternal drug concentrations (Hendrick et al., 2003 , Sit et al., 2011 While several studies indicate that SSRIs do not exert meaningful teratogenic effects, research on the consequences of these medications on fetal brain maturation has only recently been undertaken.
Preclinical studies in neonatal rodent models (equivalent to the third human trimester) indicate that SSRIs exert potent effects on brain circuitry that underlie subsequent delayed, peripubertal changes in behavior and cognition (Gingrich et al., 2017) . Rodents exhibit a developmental sensitive period to SSRIs with changes to limbic circuitry. Around puberty, behaviors evocative of depression and anxiety appear and persist for the life of the animal.
Several studies have now examined offspring exposed to SSRIs during gestation with varying reports of adverse outcomes including elevated risk for attention-deficit hyperactivity disorder (Clements et al., 2015) , depression (Brown et al., 2016) , and autism (Berard et al., 2016) . SSRI administered during pregnancy initially enters the maternal blood stream and then passes through the placenta into the fetal blood stream. At birth, the infant serum levels are approximately one third of the maternal drug concentrations. Recent results from MRI studies of infants at 3-4 weeks of age show that both prenatal SSRI use and maternal depression alter brain structure and resting state connectivity (Posner et al., 2016 , Lugo-Candelas et al., 2018 . In addition, prenatal exposure to SSRIs was found to produce subtle EEG abnormalities in the exposed newborns including reduced interhemispheric connectivity and frontal activity at low-frequency oscillations and lower crossfrequency integration. These effects were not related to maternal depression or anxiety (Videman et al., 2017) . Other characteristics of electrocortical activity that could provide early markers of alterations in brain development following these prenatal exposures have not been investigated.
In this current report we focus on a well described phenotype of early brain activity, oscillatory bursts of EEG known as delta brushes. Delta brushes are thought to be critical for establishing synaptic connections before, and in early months after, term birth (Arichi et al., 2017 , Milh et al., 2007 , Colonnese et al., 2010 , Chipaux et al., 2013 , Kaminska et al., 2017 . These bursts of electrocortical activity are characterized by distinctive high frequency oscillations of 8-20 Hz activity (i.e. brushes) superimposed on low frequency, 1-3 Hz delta activity. These distinctive patterns of EEG begin at $30 weeks post conceptional age (PCA) with the highest rate per minute at $35 weeks and lasting until $44 weeks postconceptional age (Chan et al., 2010) .
As a component of the above-mentioned MRI studies (Posner et al., 2016 , Lugo-Candelas et al., 2018 in a subset of these subjects we recorded high density (128 lead) EEGs and examined whether SSRIs and/or maternal depression altered the number or characteristics of delta brushes between 42 and 51 weeks postconceptional age. The offspring of three groups of women were assessed: those who were not depressed nor taking SSRI during pregnancy (healthy controls), those who were depressed but did not take SSRIs, and those who were taking SSRIs.
Methods

Subjects
The New York State Psychiatric Institute Institutional Review Board approved all procedures and participants provided written informed consent. Participants received financial compensation for their participation. Data were collected between January 6, 2011, and October 26, 2016. Participants (pregnant women, aged 18-45 years) were recruited through obstetricians, midwives, and psychiatrists. 77 infants had a 1-hour EEG study between 42 and 50 weeks postconceptional age: 52 were in the normal control group, 15 in the depressed group and 10 in the SSRI exposed group. Group membership was determined after mothers completed a prenatal mood and medication assessment (between 19 and 39 weeks of gestation). Mothers were assigned to the depression group if their prenatal depressive symptom score on the Center for Epidemiological Studies Depression Scale was equal to or greater than 16. Mothers were assigned to the SSRI group if they self-reported receiving any SSRI medication at some point in their pregnancy.
Of the 77 infants that provided EEG data for these analyses, 74 had data during active sleep, 64 during quiet sleep, 61 with data in both sleep states. Table 1 presents characteristics of the study infants and their mothers as well the depressive symptom scores (CED-D) for the three groups. There were significant group differences found for maternal age (from ANOVA, p < 0.001), years of mother's education (from ANOVA, p < 0.001), and distribution across ethnicity and race groups (from X 2 , p < 0.01). Post-hoc tests showed that mothers in the depressed group were younger than those in either the control (p < 0.05) or SSRI groups (p < 0.001). Mothers in the SSRI group had more years of education than either the control (p < 0.01) or depressed (p < 0.001) groups. Paralleling differences in education, significant group differences were found for the distribution of incomes across groups (overall p < 0.01; control vs SSRI, p < 0.05; SSRI vs depressed), With regard to ethnicity/ race categories, infants in the SSRI group differed from those in the control (p < 0.01) and depressed (p < 0.01) groups; no SSRI infants were from Hispanic mothers. There were, as expected, group differences in CES-D (Radloff, 1991) scores; all groups differed from each other, p < 0.05 or better.
EEG data collection
Sleeping, non-sedated infants underwent an EEG study. As all infants were more than 2 weeks post birth minimizing potential residual SSRI drug effects and withdrawal symptoms (Forsberg et al., 2014) . The recordings were collected during natural infant sleep with a 128 lead EEG system (Electrical Geodesics Inc.) sampled at 1000 samples per second. The studies of approximately 1-hour duration were processed by a custom MATLAB (Math Works, USA) algorithm that excluded data artifact (Grieve et al., 2003) and then detected and measured parameters of the EEG bursts as discussed below. In brief, neonate EEG data were processed in 30 second epochs and re-referenced to the average reference. In each epoch, data from an EEG lead (''channel") was deemed to contain artifact if the voltage was greater than 50 microvolts rms and then the channel removed from further analysis. If more than 20% of the 128 EEG channels contained artifact the entire epoch was discarded as the requirement for a valid average reference was not met (Grieve et al., 2003) . No data were interpolated across channels. Infant sleep state was determined from respiration data recorded simultaneously with the EEG using an automated sleep coding method (Isler et al., 2016) .
Delta brush detection algorithm
Data were processed in 30 second epochs. In each 30 second epoch, high frequency bursts (8-20 Hz) in the EEG were detected by the amount of their high frequency power as this feature is the characteristic that defines them as different from background EEG as described previously (Myers et al., 2012) . In brief, a timevarying spectrum was calculated for each 30 s epoch using multiple FFTs with a sliding 250 time-sample window that overlapped by one data sample and yielded a frequency resolution of $4 Hz. The 10th percentile of the sum of power in the spectral time series between 8 and 20 Hz was computed in a sliding 0.5 s window, and then smoothed with a 2 Hz low pass filter to reduce potential EKG artifact. The data smoothed with a 2 Hz low pass filter were the time series of the power in the 8-20 Hz band and not the EEG waveform data. As the neonatal pulse rate is approximately 2 Hz, smoothing prevented the false ''triggering" of burst indications from narrow EKG R-waves. The spectrum of the 8-20 Hz band power of a one-second duration burst is about 1 Hz wide and passes through the low pass filter. The choice of the 8-20 Hz detection bandwidth was adopted based on review of the literature describing high frequency oscillations in infant EEG (André et al., 2010 , Milh et al., 2007 , Tolonen et al., 2007 . Within each epoch, the beginning of a burst was identified as the time at which the 10th percentile of the smoothed 8-20 Hz power time series was exceeded and ended when it dropped below the 10th percentile.
After identifying the occurrence of bursts from the smoothed, low pass filtered tracing, each burst was characterized by its duration in seconds (i.e. time above the 10th percentile). The EEG system had a hardware high pass filter at 0.01 Hz. We collected and measured the amplitude of the slow (''delta") wave and the ''fast" (brush) oscillation. Then, from the raw EEG signal the high frequency amplitude zero to peak (microvolts) and the frequency of the oscillation (i.e. the frequency of the spectral peak with highest power) were quantified. In addition, the number of bursts per minute (rate) was computed. All four parameters characterizing bursts were measured for all epochs of active and quiet sleep.
All EEG channels were analyzed in each 30 second epoch. There are actually 129 rather than 128 as we used the average reference to obtain the EEG data for the ''reference channel" at Cz. We averaged burst data for all the leads contained in each spatial region. Details of the leads contained in each spatial region and a map of the regions is provided in our previous publications (Myers et al., 2015) .
We took care to not conflate computer-detected delta brushes with Infant sleep spindles which have an oscillation frequency of 11-15 Hz and occur only during non-REM (NREM) sleep (see Methods). Spindles first appear at 44 weeks and are longer (2-4 s) in duration than delta brushes (Ellingson, 1982 , Metcalf, 1970 , Lindemann et al., 2016 . It is unlikely that we mistakenly identified sleep spindles as delta brushes at ages greater than 44 weeks. By definition bursts less than 2 seconds in duration are characteristic of delta brushes and not of spindles. The average burst duration was 0.81 s in both sleep states. Fig. 1 is a wavelet power spectrum obtained using the Coherence software package from Natus Corporation. Shown is a 20 s segment of EEG from subject 2001 (42 weeks PMA) on lead Oz with a burst (red rectangle) with a brush oscillation spectrum of center frequency $10.5 Hz (red circle). The spectral plot horizontal axis is 20 s and vertical axis is 0-30 Hz. The burst spectrum has a yellow area showing a brush oscillation spectrum with frequency spread between 10.00-11.50 Hz (indicated in panel upper right) which is correct for a delta brush as its ''brush" has an oscillation frequency between 8 and 20 Hz and duration between 0.3 and 2 s. This burst has duration about 0.5 s. Below the yellow ''brush" spectral area there is a ''gap" in the spectrum (blue region) indicating little/no power at these frequencies and then a red region below approximately 5 Hz showing the power of the delta component. This ''two-frequency" pattern is the unique spectral signature of the delta brush and is used by the computer algorithm in its analysis of the EEG time series waveform and spectral plot to discriminate the delta brush from other oscillatory bursts with frequency between 10.25 and 11.75 Hz (blue regions on EEG trace). Fig. 2 shows the EEG traces of several delta brushes to illustrate their appearance.
Statistical analyses
One-way analyses of variance (ANOVA) were used to determine group (control, depressed, and SSRI) differences in the average values of the four burst parameters -rate per minute (rate), amplitude (zero to peak) of high frequency component (amplitude), oscillatory frequency of the burst (frequency) and burst width (duration). Each of these analyses controlled for age (PCA) at the time of the EEG assessment, race/ethnicity and sex. In total, 96 analyses were conducted; 4 burst parameters Â 12 spatial regions (left and right frontal polar, frontal, temporal, central, parietal, and occipital) Â 2 sleep states (active and quiet) sleep states. When significant (p < 0.05) differences among groups were found, post-hoc (Tukey) tests for pairwise group differences were conducted. In addition, p-values for the overall (main) effect of group from the ANOVAs that passed a False Discovery Rate threshold of 10% were also identified. A liberal 10% FDR threshold was chosen because, at least with regard to effects of SSRI (n = 10 in AS, n = 8 in QS), we viewed these results as somewhat preliminary and wanted to identify possible group differences that would warrant confirmation in follow-up studies.
Results
The p-values from the ANOVA analyses above are presented in Table 2 . For the 96 tests performed (12 regions Â 4 burst parameters Â 2 states), 16 had significant differences (p < 0.05) group differences in delta brush characteristics. To further characterize Total Family Income, $ (1 control, missing) 0-15,000 0 9 10 >15,000-25,000 0 1 4 >25,000-50,000 1 2 12 >50,000-100,000 2 2 16 >100,000-250,000 6 1 9 >250,000 1 0 0
Maternal CES-D, prenatal (mean, SD) 14.3 (14.4) 23.6 (6.8) 7.5 (4.0) (score < 16 is not depressed) these significant differences, pairwise post-hoc tests were performed. Fig. 3 , left panel, depicts in the Active Sleep state, the means and SEs for the three regions (RP, LO and RO) where there were significant group effects for the amplitude parameter. Results from post-hoc tests show that burst amplitudes in infants whose mothers were depressed during pregnancy were significantly lower in all 3 regions than for infants of healthy controls. The mean values for burst amplitudes for infants whose mothers took SSRIs were lower than controls but these differences were not significant. Amplitudes of the depressed and SSRI groups were similar and not significantly different. Fig. 3 , right panel, depicts in Active Sleep state, the oscillation frequency of the high frequency component of delta brushes. Group differences were significant in 7 regions (RFP, LF, RF, RC, RT, RP, RO). Post-hoc analyses of these regions revealed that in 5 of the 7 regions (LF, RF, RP, RT, RO) the oscillation frequency of bursts was higher in depressed or SSRI exposed infants than infants of healthy control mothers. Fig. 4, left panel, for the Quiet Sleep state, shows significant group differences in the frequency of delta brushes in 3 brain regions (LC, LO, RO). Post-hoc tests revealed that in all 3 of these regions, infants of SSRI mothers had significantly higher frequency bursts than infants of healthy controls or of infants of depressed mothers. Burst frequencies were not significantly different between the control and depressed groups in any brain region. Fig. 4 , right panel, for the Quiet Sleep state, shows significant group differences in the duration of delta brushes in 3 brain regions (LC, LT, RP). Post-hoc tests revealed that in all 3 of these regions, infants of SSRI mothers had significantly wider bursts than infants of healthy controls or infants of depressed mothers. Burst durations were not significantly different between the control and depressed groups in any brain region.
Discussion
To our knowledge, this study is the first to measure EEG delta brush activity in infants of depressed and SSRI-medicated mothers. We speculate that alterations in delta brush characteristics could be a marker of abnormal central nervous system (CNS) development as early as 6 weeks postnatally. Our results show that there is a significant effect of these prenatal exposures to maternal depression and/or SSRI use on the amplitude, frequency and duration of delta brushes but not on their rate of occurrence. We did find other regionally specific effects (See Figs. 2 and 3) :
In Active Sleep:
Maternal depression and SSRI (compared to controls) caused -delta brush amplitude to be significantly decreased -delta brush frequency to be significantly increased
In Quiet Sleep:
SSRI use, and not depression, caused significant differences -delta brush duration was significantly increased -delta brush frequency was significantly increased
Prenatal maternal depression and/or SSRI use has several possible adverse outcomes for offspring including elevated risk for attention-deficit hyperactivity disorder (Clements et al., 2015) , depression (Brown et al., 2016) , and autism (Berard et al., 2016) . Prenatal maternal psychiatric symptoms also are associated with compromised neurobehavioral development of the offspring (Grote et al., 2015) . Based on our results, we speculate that prenatal maternal depression and/or prenatal maternal use of SSRI medication might produce the above long-term effects by altering the delta brush parameters as described above.
Serotonin (5-HT) is one of brain's chief neural neurotransmitters that is widely used in neural connections and signaling and circulates in the fetal bloodstream and brain. Serotonin selective reuptake inhibitors (SSRIs) are a class of drugs used for depression medication that are ''selective" as they primarily affect serotonin, but not other neurotransmitters, increasing available serotonin at the synapse and reducing depressive symptoms. The reduced neu-ronal uptake of serotonin increases the transmitter in the synaptic cleft which can help to relieve depression (Barnes and Sharp, 1999, Herlenius and Lagercrantz, 2004) . Administering SSRI to newborn Table 2 Results from ANOVAs (p-values) for the main effect of group (control, depression, SSRI) on 4 parameters of delta brushes (rate per minute (rate), amplitude of high frequency component (ampl), burst duration, i.e. width (width), and frequency of the high frequency oscillation (freq). Results are given for each of 12 brain regions in each of two sleep states (Active and Quiet). ANOVAs included age at EEG assessment, sex and race/ethnicity (4 groups) as covariates LFP = left frontal polar, RFP = right frontal polar, LF = left frontal, RF = right frontal, LC = left central, RC = right central, LT = left temporal, RT = right temporal, LP = left parietal, RP = right parietal, LO = left occipital, RO = right occipital. p-values < 0.05 are shaded in green and p-values passing the 10% FDR threshold are shaded in yellow. Fig. 3 . Active Sleep. LEFT PANEL. Shown are means (±SE) of zero to peak amplitudes in microvolts of the high frequency oscillation component of delta brushes detected during active sleep in infants of mothers without depression or SSRIs during pregnancy (control n = 49, solid black bars), infants of mothers who were depressed during pregnancy but did not take SSRIs (depressed n = 15, striped bars), and infants of mothers who took SSRIs during pregnancy (SSRI n = 10, hatched bars). Results are shown for the three brain regions that demonstrated a main effect of group (control, depressed, SSRI) in ANOVAs (see Table 2 ). Superscript ''a" above the bar indicates significant (p < 0.05) post-hoc test (Tukey's) for the comparison between depressed and control. RP = right parietal, LO = left occipital, RO = right occipital. RIGHT PANEL. Shown are means (±SE) of the central frequency within the high frequency component of delta brushes detected during active sleep infants of mothers without depression or SSRIs during pregnancy (control n = 49, solid black bars), infants of mothers who were depressed during pregnancy but did not take SSRIs (depressed n = 15, striped bars), and infants of mothers who took SSRIs during pregnancy (SSRI n = 10, hatched bars). Results are shown for the six brain regions that demonstrated a main effect of group (control, depressed, SSRI) in ANOVAs (see Table 2 ). Superscript ''a" above the bar indicates significant (p < 0.05) post-hoc test (Tuckey's) for the comparison between depressed and control and a superscript ''b" indicates a significant (p < 0.05) post-hoc test (Tukey's) for the comparison between SSRI and control. RFP = right frontal polar, LF = left frontal, RF = right frontal, RC = right central, RP = right parietal, RO = right occipital. rats in infancy led to increases in depressive and anxious-like behaviors as adults (Ansorge et al., 2004) . This, and other results, have led to concern regarding the use of SSRIs as a treatment for depression during human pregnancy (Gingrich et al., 2017) . Based on animal studies, delta brushes are similar in origin and function to ''spindle bursts" and arise from thalamocortical/subplate circuit activity (Murata and Colonnese, 2019) . The amplitude of spindle bursts in infant rats have been shown to be reduced by an intraperitoneal injection of a commonly used SSRI, citalopram (Akhmetshina et al., 2016) . Importantly, CNS serotonin may be increased by untreated maternal depression. Maternal depression causes a reduction in MAO A, an enzyme present in the placenta, which breaks down serotonin and decreases the level in the infant. Thus, infants of mothers with untreated depression would, like infants exposed to SSRIs, have elevated levels of serotonin (Blakeley et al., 2013) . The finding of lower amplitude delta brushes in active sleep may be related to the prenatal exposure to elevated levels of serotonin, however it is unclear why this effect is seen only in active sleep.
The literature shows a relationship between depression and changes in the insula of the depressed adults (Yin et al., 2018) . Interestingly, offspring of depressed mothers showed increased functional connectivity of the amygdala with the left temporal cortex and insula similar to that observed in adults with major depressive disorder (Qiu et al., 2015) . Further, right insular volume expansion and increased white matter structural connectivity with the right amygdala were also shown in infants of mothers who used SSRI medication during pregnancy (Lugo-Candelas et al., 2018) . Hence another possible cause of delta brush alteration resulting from maternal depression and/or SSRI medication may be mediated by changes in the insula. Consistent with this hypothesis the insula is the location of the major fMRI bold signal activity associated with delta brush occurrence (Arichi et al., 2017) . At this point it is not understood why changes in either connectivity or volume of the insula should alter the parameters of delta brushes selectively. This is a potential avenue for translational research. A limitation in comparing our behavioral-state related results with previous fMRI functional results for delta brush activity (Barnes and Sharp, 1999 , Posner et al., 2016 , Arichi et al., 2017 is that behavioral state was not noted in these prior studies.
Finally, as delta brushes are a key marker of infant neurodevelopment and synapse formation (Whitehead et al., 2017) the changes discussed here show that these important processes might be affected. We speculate that decreases in delta brush amplitude and increases in oscillation frequency and duration would serve as early markers for possible infant neurodevelopmental problems. Whitehead showed that frequency and amplitude decrease from 34 weeks to term age. No variation in width with age was mentioned. The increases in amplitude and frequency found here may indicate delayed maturation (Whitehead et al., 2017) .
These early results do not enable us to address mechanisms or recommendations for treatment of prenatal maternal depression. As this is the first study showing substantial differences in delta brushes related to maternal depression, correlations with the long-term neurodevelopmental status of offspring of mothers with untreated depression and/or SSRI administration needs to be undertaken. Further, as our infant studies took place several weeks after birth, it is possible that factors in the postpartum environment could have affected the burst measurements. However, as the mean age of the infant at EEG was less than 6 weeks postnatal age, it is unlikely that this period of exposure had a significant effect compared to the duration of the pregnancy. Finally, our subject numbers (10) for SSRI users were small and need to be increased for future studies of SSRI effects. We are not able to postulate a ''mechanism" by which the delta brush changes observed were causal or related to eventual neurodevelopmental deficits of the offspring. It may be that earlier delta brush characterization at birth paired with neurodevelopmental testing later in development will facilitate our understanding of the developmental mechanisms.
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